One plan - full access

No subscription, no auto-renewal, no hidden terms.
Pay once and use it for 30 days.

PRO plan No auto-renewal
$18

30 days of full access
One-time payment

🌐 US & Global Companies
Get access for 30 days →
♧ Secure payment · Instant access

What is included

  • ✓Full access to detailed company analysis
  • ✓Fundamental screener
  • ✓Advanced stock screener filters
  • ✓5 ratings. Separate lists for US & Global Companies and MOEX
  • ✓Company data export in XLSX and CSV
  • ✓MarketCap’s overall ranking of top companies
  • ✓Analytics updates after each new financial report
⚠ The service is not an investment advisor. Financial statement data from public companies is available to everyone - MarketCap structures and analyzes it.
Delcath Systems logo
Delcath Systems DCTH
$ 20.08 1.06%
report update icon

Quarterly report 2026-Q3
added 11-09-2026

Delcath Systems Balance Sheet 2025-1988 | DCTH

Brief overview of Delcath Systems's financial position

The comparison uses five available annual reports from the 2021–2025 interval.

Total assets increased by +273.2%, from $33.1 million to $123.6 million. A CAGR near 39% points to substantial expansion.

Liabilities grew more slowly than assets: -41.4% versus +273.2%. Expansion relied more on equity, improving funding quality.

Equity accounts for 90% of assets. Against the initial 36.1%, the capital position looks resilient.

Negative net debt of -$42.5 million means cash holdings are larger than debt obligations.

Cash accounts for 35.1% of assets versus 68.8% initially. The change indicates the degree of financial flexibility.

Retained earnings are negative at -$528.8 million. This reduces the formal capital cushion, although large shareholder returns may have contributed.

Overall picture

The indicators point to a strong balance sheet position for Delcath Systems: funding is balanced and liability risks appear controlled.

Annual Balance Sheet Delcath Systems

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 1988

Net Debt

-42.5 M -31.4 M -2.46 M 8.2 M -22.2 M -27.6 M -7.14 M -478 K -4 M 8.93 M -12.6 M -20.5 M -31.2 M -23.7 M -25.8 M - - - -

Long Term Debt

835 K 933 K 10.2 M 15.7 M 207 K 450 K 2 M - - - - - - - - - - - -

Long Term Debt Current

101 K 105 K 37 K 186 K 416 K 495 K 664 K - - - - - - - - - - - -

Total Non Current Liabilities

1.46 M 1.7 M 6.39 M 8.99 M 15.2 M 2.52 M 5.06 M 4.03 M 395 K 634 K 820 K 1.04 M 366 K 309 K 300 K - - - -

Total Current Liabilities

11 M 6.14 M 16.4 M 14.7 M 5.95 M 10 M 15.5 M 17.8 M 7.81 M 36.1 M 6.31 M 4.58 M 6.63 M 10.2 M 8.84 M 21.2 M - - -

Total Liabilities

12.4 M 7.84 M 22.8 M 23.7 M 21.2 M 12.6 M 20.6 M 21.8 M 8.21 M 36.7 M 7.13 M 5.62 M 7 M 10.5 M 9.14 M - - - -

Deferred Revenue

- - - - 170 K 525 K - - - - - - - - - - - - -

Retained Earnings

-529 M -532 M -505 M -457 M -421 M - -371 M -344 M -325 M -279 M -261 M -247 M -229 M -199 M -147 M - - - -

Total Assets

124 M 76.6 M 38.6 M 17.9 M 33.1 M 34.6 M 14.2 M 6.84 M 8.89 M 35.2 M 15.7 M 23.8 M 37.1 M 30.5 M 35.2 M 50.6 M - - -

Cash and Cash Equivalents

43.5 M 32.4 M 12.6 M 7.67 M 22.8 M 28.6 M 10 M 2.52 M 4 M 4.41 M 12.6 M 20.5 M 31.2 M 23.7 M 25.8 M 45.6 M 35.5 M 6.94 M -

Book Value

111 M 68.7 M 15.8 M -5.86 M 12 M 22.1 M -6.36 M -14.9 M 678 K -1.49 M 8.6 M 18.1 M 30.1 M 20 M 26.1 M 50.6 M - - -

Total Shareholders Equity

111 M 68.7 M 15.8 M -5.86 M 12 M 22.1 M -6.36 M -14.9 M 678 K -1.49 M 8.6 M 18.1 M 30.1 M 20 M 26.1 M 29.1 M 23.8 M 10.2 M -

All numbers in USD currency

Quarterly Balance Sheet Delcath Systems

2026-Q3 2026-Q2 2026-Q1 2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

2.21 M 2.27 M 815 K 835 K 855 K 877 K 906 K 933 K 963 K 989 K 1.02 M 10.2 M - - - 15.7 M - 113 K 122 K 207 K 318 K 263 K 357 K 450 K 542 K 17 K 450 K 197 K 197 K 197 K 197 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

2.53 M 2.59 M 1.43 M 1.46 M 1.44 M 1.46 M 1.8 M 1.7 M 1.53 M 17.4 M 8.14 M 6.39 M 8.88 M 10.2 M 11.9 M 8.99 M 11 M 11.7 M 13.4 M 15.2 M 17.3 M 4.02 M 2.21 M 2.52 M 2.64 M 4.63 M - 4.58 M - - - 4.03 M 650 K 466 K 345 K 395 K - - - 634 K 7.11 M 2.3 M 767 K 820 K 874 K 929 K 5.23 M 5.62 M 1.09 M 748 K 225 K 7 M 497 K 366 K 366 K 309 K 309 K - - - - - -

Total Liabilities

15.6 M 15.9 M 12.1 M 12.4 M 9.45 M 11.9 M 7.09 M 7.84 M 23.1 M 29.7 M 21.5 M 22.8 M 22.9 M 21.3 M 25.3 M 23.7 M 25.5 M 23.9 M 22.1 M 21.2 M 22.7 M 9.76 M 12.3 M 12.6 M 13.3 M 12.7 M 12.6 M 20.6 M 20.6 M 20.6 M 20.6 M 21.8 M 17.7 M 18.6 M 12.6 M 8.21 M 8.21 M 8.21 M 8.21 M 36.7 M 32.5 M 36 M 4.67 M 7.13 M 6.05 M 4.28 M 7.13 M 5.62 M 5.62 M 5.62 M 6.43 M 7 M - 7 M 6.64 M - - - - - - - -

Deferred Revenue

- - - - - - - - - - - - - - - - - - - 170 K 496 K 509 K 502 K 525 K 501 K 525 K 525 K 482 K 482 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

-520 M -527 M -530 M -529 M -527 M -528 M -530 M -532 M -528 M -530 M -516 M -505 M -494 M -474 M -466 M -457 M -447 M -439 M -429 M -421 M -416 M -409 M -402 M -395 M -388 M -383 M -395 M -371 M -371 M -371 M -371 M -344 M -333 M -324 M -318 M -325 M -325 M -325 M -325 M -279 M -271 M -270 M -263 M -261 M -256 M -254 M -261 M -247 M -247 M -247 M -247 M -229 M -224 M -217 M -212 M -199 M -199 M -199 M -199 M - - - -

Total Assets

149 M 137 M 125 M 124 M 124 M 117 M 87.3 M 76.6 M 31.7 M 33.9 M 36.1 M 38.6 M 47.6 M 21 M 30.6 M 17.9 M 20.2 M 21.1 M 27.3 M 33.1 M 34.4 M 24.9 M 32.3 M 34.6 M 16.6 M 20.4 M 34.6 M 14.2 M 14.2 M 14.2 M 14.2 M 6.84 M 12.8 M 5.47 M 6.42 M 8.89 M 8.89 M 8.89 M 8.89 M 35.2 M 37 M 41.4 M 12.5 M 15.7 M 19.6 M 17.4 M 15.7 M 23.8 M 23.8 M 23.8 M 23.8 M 37.1 M 33.3 M 38.4 M 49.5 M 30.5 M 35 M 35.1 M 25.6 M 35.2 M 49 M 35.6 M 35.2 M

Cash and Cash Equivalents

55.5 M 47.5 M 41.3 M 43.5 M 41.8 M 34.4 M 12.8 M 32.4 M 8.3 M 14.8 M 11.8 M 12.7 M 40.5 M 14.6 M 24.3 M 11.8 M 9.83 M 10.2 M 16.3 M 22.8 M 24.9 M 19.3 M 26.6 M 28.6 M 10.9 M 16 M 28.6 M 10 M 10 M 10 M 10 M 2.52 M 8.91 M 1.28 M 2.03 M 4 M 4 M 4 M 4 M 4.41 M 3.69 M 1.82 M 9.54 M 12.6 M 16.7 M 14.1 M 12.6 M 20.5 M 20.5 M 20.5 M 20.5 M 31.2 M 27.7 M 32.3 M 42.8 M 23.7 M 28.3 M 29.3 M 17 M 25.8 M 41 M 31.1 M 25.8 M

Book Value

134 M 121 M 113 M 111 M 115 M 105 M 80.2 M 68.7 M 8.57 M 4.19 M 14.6 M 15.8 M 24.7 M -242 K 5.29 M -5.86 M -5.25 M -2.85 M 5.22 M 12 M 11.7 M 15.2 M 20 M 22.1 M 3.28 M 7.7 M 22.1 M -6.36 M -6.36 M -6.36 M -6.36 M -14.9 M -4.86 M -13.1 M -6.2 M 678 K 678 K 678 K 678 K -1.49 M 4.49 M 5.43 M 7.86 M 8.6 M 13.5 M 13.1 M 8.6 M 18.1 M 18.1 M 18.1 M 17.3 M 30.1 M 33.3 M 31.4 M 42.9 M 30.5 M 35 M 35.1 M 25.6 M 35.2 M 49 M 35.6 M 35.2 M

Total Shareholders Equity

134 M 121 M 113 M 111 M 115 M 105 M 80.2 M 68.7 M 8.57 M 4.19 M 14.6 M 15.8 M 24.7 M -242 K -13.1 M -5.86 M -5.25 M -2.85 M 5.22 M 12 M 11.7 M 15.2 M 20 M 22.1 M 3.28 M 7.7 M 22.1 M -6.36 M -6.36 M -6.36 M -6.36 M -14.9 M -4.86 M -13.1 M -6.2 M 678 K 678 K 678 K 678 K -1.49 M 4.49 M 5.43 M 7.86 M 8.6 M 13.5 M 13.1 M 8.6 M 18.1 M 18.1 M 18.1 M 18.1 M 30.1 M 27.9 M 33.1 M 38.4 M 20 M 24.9 M 21.5 M 16.8 M 26.1 M 40.5 M 24.3 M 26.1 M

All numbers in USD currency

Balance Sheet is a fundamental financial report of Delcath Systems, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.

For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.

Features of balance sheet analysis
  • Vertical and horizontal analysis
    Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods.
  • Asset quality
    It is important to evaluate not only the amount of assets but also their liquidity and realizability.
  • Accounting for off-balance sheet liabilities
    Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.

Balance sheet of other industry stocks – Medical devices

Issuer Price % 24h Market Cap Country
Tandem Diabetes Care Tandem Diabetes Care
TNDM
$ 18.7 2.92 % $ 1.27 B usaUSA
CHF Solutions, Inc. CHF Solutions, Inc.
CHFS
- 1.15 % $ 34.5 M usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
- -1.42 % $ 435 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
- 0.03 % $ 1.58 B israelIsrael
Misonix, Inc. Misonix, Inc.
MSON
- - $ 462 M usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
- - $ 955 M usaUSA
AdaptHealth Corp. AdaptHealth Corp.
AHCO
$ 7.72 4.97 % $ 1.04 B usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
- -4.14 % $ 702 M usaUSA
Inspire Medical Systems Inspire Medical Systems
INSP
$ 62.36 -3.06 % $ 1.83 B usaUSA
Integer Holdings Corporation Integer Holdings Corporation
ITGR
$ 126.66 0.08 % $ 4.4 B usaUSA
Avanos Medical Avanos Medical
AVNS
$ 24.99 - $ 1.16 B usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
- 1.37 % $ 20.5 M usaUSA
BioSig Technologies BioSig Technologies
BSGM
- 37.08 % $ 85.7 M usaUSA
Helius Medical Technologies Helius Medical Technologies
HSDT
$ 1.83 -4.69 % $ 40.3 M usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
- 14.99 % $ 929 K usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
- -0.97 % $ 54.4 M usaUSA
FONAR Corporation FONAR Corporation
FONR
- - $ 140 M usaUSA
GBS GBS
GBS
- -0.57 % $ 7.12 M usaUSA
NanoVibronix NanoVibronix
NAOV
- - $ 1.08 M usaUSA
Ra Medical Systems Ra Medical Systems
RMED
- 10.0 % $ 610 K usaUSA
ReWalk Robotics Ltd. ReWalk Robotics Ltd.
RWLK
- 7.07 % $ 66.1 M israelIsrael
STRATA Skin Sciences STRATA Skin Sciences
SSKN
- - $ 6.6 M usaUSA
Abbott Laboratories Abbott Laboratories
ABT
$ 110.59 0.07 % $ 193 B usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
- - $ 162 M franceFrance
Align Technology Align Technology
ALGN
$ 174.54 0.16 % $ 12.7 B usaUSA
TELA Bio TELA Bio
TELA
$ 0.83 -4.37 % $ 39 M usaUSA
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
EW
$ 104.0 -0.68 % $ 60.8 B usaUSA
Avinger Avinger
AVGR
- -20.74 % $ 369 K usaUSA
CONMED Corporation CONMED Corporation
CNMD
$ 51.21 -1.42 % $ 1.59 B usaUSA
Medtronic PLC Medtronic PLC
MDT
$ 101.59 -1.17 % $ 130 B usaUSA
MiMedx Group MiMedx Group
MDXG
$ 3.37 1.36 % $ 498 M usaUSA
ThermoGenesis Holdings ThermoGenesis Holdings
THMO
- -25.84 % $ 171 K usaUSA
Talis Biomedical Corporation Talis Biomedical Corporation
TLIS
- 3.55 % $ 7.96 M usaUSA
Myomo Myomo
MYO
$ 1.32 -5.71 % $ 55.2 M usaUSA
Insulet Corporation Insulet Corporation
PODD
$ 148.03 -1.19 % $ 10.4 B usaUSA
Profound Medical Corp. Profound Medical Corp.
PROF
$ 7.66 4.36 % $ 232 M canadaCanada
Quanterix Corporation Quanterix Corporation
QTRX
$ 3.3 -2.51 % $ 141 M usaUSA
Viveve Medical Viveve Medical
VIVE
- -15.35 % $ 1.71 M usaUSA
Smith & Nephew plc Smith & Nephew plc
SNN
$ 30.96 -0.29 % $ 26.8 B britainBritain
Sensus Healthcare Sensus Healthcare
SRTS
$ 3.42 7.39 % $ 55.8 M usaUSA
Stryker Corporation Stryker Corporation
SYK
$ 324.18 -0.48 % $ 124 B usaUSA
Tactile Systems Technology Tactile Systems Technology
TCMD
$ 26.61 0.08 % $ 609 M usaUSA
TransMedics Group TransMedics Group
TMDX
$ 91.02 -2.95 % $ 3.09 B usaUSA
SmileDirectClub SmileDirectClub
SDC
- -53.45 % $ 9.71 M usaUSA
Viemed Healthcare Viemed Healthcare
VMD
$ 9.04 1.01 % $ 352 M usaUSA
Varex Imaging Corporation Varex Imaging Corporation
VREX
$ 18.45 0.03 % $ 764 M usaUSA
Acutus Medical Acutus Medical
AFIB
- -26.83 % $ 2.62 M usaUSA
Vivos Therapeutics Vivos Therapeutics
VVOS
$ 0.09 -8.14 % $ 925 K usaUSA
BIOLASE BIOLASE
BIOL
- -13.19 % $ 166 K usaUSA
SeaSpine Holdings Corporation SeaSpine Holdings Corporation
SPNE
- 0.28 % $ 270 M usaUSA